Discovery of chalcone derivatives as potential α-glucosidase and cholinesterase inhibitors: Effect of hyperglycemia in paving a path to dementia

[1]  B. Bradshaw,et al.  Cytotoxic Effects on Breast Cancer Cell Lines of Chalcones Derived from a Natural Precursor and Their Molecular Docking Analysis , 2022, Molecules.

[2]  Sanjay Kumar,et al.  Design, synthesis and in-silico & in vitro enzymatic inhibition assays of pyrazole-chalcone derivatives as dual inhibitors of α-amylase & DPP-4 enzyme , 2022, Chemical Papers.

[3]  Reem I. Alsantali,et al.  Synthesis and Evaluation of 1,3,5-Triaryl-2-Pyrazoline Derivatives as Potent Dual Inhibitors of Urease and α-Glucosidase Together with Their Cytotoxic, Molecular Modeling and Drug-Likeness Studies , 2022, ACS omega.

[4]  S. Chander,et al.  Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation. , 2021, Bioorganic chemistry.

[5]  Shujaat Ahmad,et al.  Neuroprotective Potential of Synthetic Mono-Carbonyl Curcumin Analogs Assessed by Molecular Docking Studies , 2021, Molecules.

[6]  M. Mirzaei,et al.  2-Benzylidenebenzofuran-3(2H)-ones as a new class of alkaline phosphatase inhibitors: synthesis, SAR analysis, enzyme inhibitory kinetics and computational studies , 2021, RSC advances.

[7]  L. Nahar,et al.  Chalcones: Synthetic Chemistry Follows Where Nature Leads , 2021, Biomolecules.

[8]  G. Hailu,et al.  Design, Synthesis, Characterization and in vivo Antidiabetic Activity Evaluation of Some Chalcone Derivatives , 2021, Drug design, development and therapy.

[9]  M. Peitsch,et al.  Differential effects of alkaloids on memory in rodents , 2021, Scientific Reports.

[10]  S. L. Manju,et al.  Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations , 2021, Journal of enzyme inhibition and medicinal chemistry.

[11]  B. Kumar,et al.  Study of adsorption mechanism of chalcone derivatives on mild steel-sulfuric acid interface , 2020 .

[12]  S. Muhammad,et al.  Design and synthesis of new flavonols as dual ɑ-amylase and ɑ-glucosidase inhibitors: Structure-activity relationship, drug-likeness, in vitro and in silico studies , 2020 .

[13]  Ü. Demirbaş,et al.  Synthesis, anti-cholinesterease, α-glucosidase inhibitory, antioxidant and DNA nuclease properties of non-peripheral triclosan substituted metal-free, copper(II), and nickel(II) phthalocyanines , 2020 .

[14]  K. Thai,et al.  Synthesis, In Silico and In Vitro Evaluation for Acetylcholinesterase and BACE-1 Inhibitory Activity of Some N-Substituted-4-Phenothiazine-Chalcones , 2020, Molecules.

[15]  M. Zafar,et al.  Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure–activity relationship and molecular modelling simulations , 2020, Journal of biomolecular structure & dynamics.

[16]  H. Wahab,et al.  Anti-cholinesterase potential of diverse botanical families from Malaysia: Evaluation of crude extracts and fractions from liquid-liquid extraction and acid-base fractionation. , 2019, Journal of ethnopharmacology.

[17]  I. Gulcin,et al.  Synthesis of novel tris-chalcones and determination of their inhibition profiles against some metabolic enzymes , 2019, Archives of physiology and biochemistry.

[18]  H. Ragab,et al.  Chlorinated tacrine analogs: Design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer's disease. , 2019, Bioorganic chemistry.

[19]  M. Albert,et al.  The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study , 2019, Diabetes Care.

[20]  Reza Ghadimi,et al.  Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study. , 2019, Bioorganic chemistry.

[21]  Víctor García-González,et al.  Synthesis, Biological Evaluation and Docking Studies of Chalcone and Flavone Analogs as Antioxidants and Acetylcholinesterase Inhibitors , 2019, Applied Sciences.

[22]  R. Ullah,et al.  Anticholinesterase, antioxidant potentials, and molecular docking studies of isolated bioactive compounds from Grewia optiva , 2019, International Journal of Food Properties.

[23]  R. Anwar,et al.  Lavandula stoechas (L) a Very Potent Antioxidant Attenuates Dementia in Scopolamine Induced Memory Deficit Mice , 2018, Front. Pharmacol..

[24]  I. Matić,et al.  Novel 1,3,4-thiadiazole-chalcone hybrids containing catechol moiety: synthesis, antioxidant activity, cytotoxicity and DNA interaction studies. , 2018, MedChemComm.

[25]  F. Feng,et al.  Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. , 2018, European journal of medicinal chemistry.

[26]  S. Antimisiaris,et al.  Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[27]  A. Al-Qahtani,et al.  Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease , 2018, BMC Structural Biology.

[28]  Mohd. R. Razali,et al.  Synthesis, characterization, X-ray crystal structures of heterocyclic Schiff base compounds and in vitro cholinesterase inhibition and anticancer activity , 2017 .

[29]  S. Gaonkar,et al.  Synthesis and pharmacological properties of chalcones: a review , 2017, Research on Chemical Intermediates.

[30]  C. Xing,et al.  Chalcone: A Privileged Structure in Medicinal Chemistry. , 2017, Chemical reviews.

[31]  Yong Rao,et al.  Analogues of xanthones--Chalcones and bis-chalcones as α-glucosidase inhibitors and anti-diabetes candidates. , 2017, European journal of medicinal chemistry.

[32]  S. Vilar,et al.  New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies. , 2017, Bioorganic & medicinal chemistry.

[33]  S. Nabavi,et al.  Heterocyclic Compounds: Effective α-Amylase and α-Glucosidase Inhibitors. , 2016, Current topics in medicinal chemistry.

[34]  A. Verma,et al.  α-Mangostin Mediated Pharmacological Modulation of Hepatic Carbohydrate Metabolism in Diabetes Induced Wistar Rat , 2016 .

[35]  K. Thai,et al.  Synthesis of Novel Chalcones as Acetylcholinesterase Inhibitors , 2016 .

[36]  Guangcheng Wang,et al.  Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors. , 2016, Bioorganic & medicinal chemistry letters.

[37]  O. Oguntibeju,et al.  Hypoxis hemerocallidea Significantly Reduced Hyperglycaemia and Hyperglycaemic-Induced Oxidative Stress in the Liver and Kidney Tissues of Streptozotocin-Induced Diabetic Male Wistar Rats , 2016, Evidence-based complementary and alternative medicine : eCAM.

[38]  Tih-Shih Lee,et al.  Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort. , 2016, JAMA neurology.

[39]  A. Doğan,et al.  Healing effects of sumac (Rhus coriaria) in streptozotocin-induced diabetic rats , 2016, Pharmaceutical biology.

[40]  Qiu-an Wang,et al.  Novel Potent and Selective Acetylcholinesterase Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease: Synthesis, Pharmacological Evaluation, and Molecular Modeling of Amino‐Alkyl‐Substituted Fluoro‐Chalcones Derivatives , 2015, Chemical biology & drug design.

[41]  N. Tong,et al.  Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review , 2015, Expert opinion on pharmacotherapy.

[42]  A. Tiwari,et al.  Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity. , 2015, European journal of medicinal chemistry.

[43]  N. Ismail,et al.  Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies. , 2015, European journal of medicinal chemistry.

[44]  H. Ullah,et al.  Triazinoindole analogs as potent inhibitors of α-glucosidase: synthesis, biological evaluation and molecular docking studies. , 2015, Bioorganic chemistry.

[45]  N. Ali,et al.  In vitro acetylcholinesterase and butyrylcholinesterase inhibitory potentials of essential oil of Artemisia macrocephala , 2015 .

[46]  R. Ertan,et al.  Spectral Properties of Chalcones II , 2015 .

[47]  Vipan Kumar,et al.  Recent developments in biological activities of chalcones: a mini review. , 2014, European journal of medicinal chemistry.

[48]  H. Levine,et al.  Design, synthesis and biological activity of multifunctional α,β-unsaturated carbonyl scaffolds for Alzheimer's disease. , 2013, Bioorganic & medicinal chemistry letters.

[49]  R. Guedes,et al.  Five-membered iminocyclitol α-glucosidase inhibitors: synthetic, biological screening and in silico studies. , 2013, Bioorganic & medicinal chemistry.

[50]  P. Hollander.  Safety Profile of Acarbose, an α-Glucosidase Inhibitor , 2012, Drugs.

[51]  K. Zhou,et al.  Grape skin extract inhibits mammalian intestinal α-glucosidase activity and suppresses postprandial glycemic response in streptozocin-treated mice , 2011 .

[52]  Bo-Han Su,et al.  In Silico Binary Classification QSAR Models Based on 4D-Fingerprints and MOE Descriptors for Prediction of hERG Blockage , 2010, J. Chem. Inf. Model..

[53]  C. Kaiser,et al.  Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as alpha-glucosidases inhibitors. , 2010, Journal of medicinal chemistry.

[54]  Jitender Verma,et al.  3D-QSAR in drug design--a review. , 2010, Current topics in medicinal chemistry.

[55]  Lei Wang,et al.  (E)-3-[4-(Dimethylamino)phenyl]-1-(4-methylphenyl)prop-2-en-1-one , 2009, Acta crystallographica. Section E, Structure reports online.

[56]  B. Suresh,et al.  Synthesis and Biological evaluation of some heterocyclic derivatives of Chalcones , 2009 .

[57]  F. Monache,et al.  Structure-activity relationship of antibacterial chalcones. , 2008, Bioorganic & medicinal chemistry.

[58]  R. Butcher,et al.  (2E)‐1‐(4‐Methylphenyl)‐3‐(4‐nitrophenyl)prop‐2‐en‐1‐one , 2007 .

[59]  R. Butcher,et al.  (E)-3-(4-Fluorophenyl)-1-(4-methylphenyl)prop-2-en-1-one , 2007 .

[60]  Atta-ur-rahman,et al.  Syntheses and Biological Activities of Chalcone and 1,5‐Benzothiazepine Derivatives: Promising New Free‐Radical Scavengers, and Esterase, Urease, and α‐Glucosidase Inhibitors , 2005 .

[61]  X. Wu,et al.  Chalcones: an update on cytotoxic and chemoprotective properties. , 2005, Current medicinal chemistry.

[62]  D. Lorke.  A new approach to practical acute toxicity testing , 1983, Archives of Toxicology.

[63]  E. Barrett-Connor,et al.  Diabetes, impaired fasting glucose, and development of cognitive impairment in older women , 2004, Neurology.

[64]  Wolfgang Liebl,et al.  Crystal structure of Thermotoga maritima 4-alpha-glucanotransferase and its acarbose complex: implications for substrate specificity and catalysis. , 2002, Journal of molecular biology.

[65]  Sugiyanto,et al.  Synthesis of benzylideneacetophenones and their inhibition of lipid peroxidation. , 2000, European journal of medicinal chemistry.

[66]  C. Cheeseman,et al.  Inhibition of glucose absorption in the rat jejunum: a novel action of alpha-D-glucosidase inhibitors. , 1997, Gastroenterology.

[67]  T. Nagao,et al.  Studies on a new 1,5-benzothiazepine derivative (CRD-401). IV. Coronary vasodilating effect and structure-activity relationship. , 1973, Chemical & pharmaceutical bulletin.